Psychiatr. pro Praxi, 2009; 10(5): 241-242

Treatment strategy for bipolar affective disorder

MUDr. Jiří Janatka1, MUDr. Stanislav Morávek1, MUDr. Vlastimil Tichý2
1 Psychiatrické oddělení ÚVN Praha
2 Ústřední vojenská nemocnice Praha

The aim of our work was to determine current practices in pharmacotherapeutic procedures when treating bipolar affective disorders

in our ambulatory practice and to assess their suitability and efficacy. We also focused on decision-making processes when determining

treatment, mainly in relation to prescribing antipsychotics.

Keywords: bipolar affective disorder, prophylaxis, decision-making processes, mood stabilizers, antipsychotics, antidepressants.

Published: November 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janatka J, Morávek S, Tichý V. Treatment strategy for bipolar affective disorder. Psychiatr. praxi. 2009;10(5):241-242.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. International Journal of Neuropsychopharmacology, Page 1-31, Copyright 2008 CINP. Go to original source... Go to PubMed...
    2. Tohen M, Lin DY. Olanzapin as Maintenance Therapy in Patients with Bipolar I Disorder. Progress in Neurotherapeutics and Neuropsychopharmacology 2007; 2(1): 225-238. Cambridge University Press. Go to original source...
    3. Yatham LN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disorders 2006; 8: 721-739. Go to original source... Go to PubMed...
    4. Herman E, Praško J, Hovorka J. Místo stabilizátorů nálady v léčbě bipolární poruchy, Psychiatrie pro praxi 2002; 3: 94-101.
    5. Švestka J. Olanzapin v léčbě afektivních poruch. Psychiatrie 2003; 7(3): 194-202.
    6. Grof P, Tůma I. Bipolární stabilizátory nálady: Jaký, pro koho, kdy a jak dlouho? Psychiatrie 2004; 8(4): 315-320.
    7. Tůma I. Antipsychotika druhé generace v léčbě bipolární poruchy. Psychiatrie pro praxi 2005; 5: 220-224.
    8. Češková E, Herman E, Doubek P, Praško J. Bipolární afektivní porucha in Doporučené postupy psychiatrické péče II, Infopharm, a.s., 2006: 88-93.
    9. Herman E, Grof P, Hovorka J, Praško J, Doubek P. Bipolární afektivní porucha in Postupy v léčbě psychických poruch 2004: 113-115. Algoritmy České neuropsychofarmakologické společnosti 2008: 132-166.
    10. Baldessarini RJ, et al. Olanzapine versus placebo in acute mania: treatment responses in subgroups. J. Clin. Psychopharmacol 2003; 23(4): 370-376. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.